Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.
Japan Approves Worlds First iPS Therapies for Parkinsons, Heart Failure Conditional approval granted for Sumitomo Pharmas ...
Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and the Ludwig Institute for Cancer Research have discovered that neutrophils, a ...
Viruses have spent billions of years perfecting the art of invading cells, hijacking their machinery and spreading with ruthless efficiency. Now researchers are turning that evolutionary expertise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results